Literature DB >> 2045704

PIVKA-II (protein induced by vitamin K absence-II) status in newborns exposed to anticonvulsant drugs in utero.

T Anai1, Y Hirota, M Oga, J Yoshimatsu, I Miyakawa.   

Abstract

Using PIVKA-II and Hepaplastin test, 5 neonates exposed to anticonvulsant drugs in utero were assessed 5 days after birth. None showed any sign of clinical bleeding, but all had PIVKA-II values over 1 microgram/ml. In controls, only 96 of 1,166 (8.2%) neonates had PIVKA-II values over 1 microgram/ml. The difference in the incidence rate was significant (p less than 0.005). Three of 5 epileptic mothers received valproatic acid and/or diazepam but no barbiturates and/or hydantoin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045704

Source DB:  PubMed          Journal:  Nihon Sanka Fujinka Gakkai Zasshi        ISSN: 0300-9165


  2 in total

Review 1.  Treatment of epilepsy in pregnancy.

Authors:  I Nulman; D Laslo; G Koren
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

Review 2.  Vitamin K in neonates: how to administer, when and to whom.

Authors:  E Autret-Leca; A P Jonville-Béra
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.930

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.